Please use this identifier to cite or link to this item:
https://hdl.handle.net/20.500.14365/5469| Title: | Impact of hepatitis B virus (HBV) infection on efficacy and safety in the KEYNOTE-966 study of pembrolizumab (pembro) plus gemcitabine and cisplatin (gem/cis) for advanced biliary tract cancer (BTC) | Authors: | Yau, Thomas Chan, Stephen Lam Kelley, Robin Kate Finn, Richard S. Yoo, Changhoon Furuse, Junji Ren, Zhenggang |
Publisher: | Lippincott williams & wilkins | URI: | https://hdl.handle.net/20.500.14365/5469 | ISSN: | 0732-183X 1527-7755 |
| Appears in Collections: | WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
Show full item record
CORE Recommender
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.